-
effectivehealthcare.ahrq.gov/products/bladder-cancer-muscle-invasive/research-protocol
July 21, 2014 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … Stage T4b cancer, in which the tumor has spread to the pelvis or abdominal wall, bladder cancer involving … Approximately 25 percent of newly diagnosed bladder cancers present as stage 2 or higher tumors. 6 Once … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … and Treatment of Non-metastatic Muscle-invasive Bladder Cancer
exp Urinary Bladder Neoplasms/ (42649
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-radiation/research
November 30, 2012 - outcomes, especially in higher risk tumors, although evidence is lacking. … Prior examinations of the same database have shown tumor characteristics such as size or stage to be … Higher doses of CRT are associated with lower tumor recurrence rates. … If CRT becomes less accessible, we may expect IMRT use to increase in other tumors, perhaps even in tumors … Monitoring IMRT use should be a priority for these other cancers as well as for groups of prostate cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
October 01, 2014 - Executive Summary
Background and Objectives
Hepatocellular carcinoma (HCC) is
the most common primary malignant … neoplasm of the liver, usually developing
in individuals with chronic liver disease
or cirrhosis. … Worldwide, it is the fifth
most common cancer and the third most
common cause of cancer death.1 There … National Cancer Institute. Liver Cancer. www.cancer.gov/
cancertopics/types/liver. … SEER Cancer
Statistics Review, 1975-2010.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
November 28, 2012 - Unlike most solid
tumors, the future incidence of and mortality rate due to HCC are projected to increase … using the following string of search terms:
"Carcinoma, Hepatocellular"[Mesh] OR (hepatocellular AND (neoplasm … * OR cancer OR
cancers OR carcinoma)) AND Unresectable OR nonresectable OR inoperable OR irresectable … comparative studies, and case
series by using the following string of search terms:
hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma) AND (unresectable OR
nonresectable OR inoperable OR irresectable
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-non-muscle-invasive-bladder-cancer
October 03, 2012 - , cystoscopy, urine cytology, urine-based biomarkers, transurethral resection of bladder tumor (TURBT … How do tumor characteristics (stage, grade, multiplicity, size, molecular and genetic alterations) predict … perhaps replace cytology and cystoscopy in the diagnosis and surveillance of patients with urothelial cancers … Genetic and epidemiological evidence indicates that African Americans may have a more aggressive form of malignancy … for 90% of all malignant tumors.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
May 01, 2013 - One study reported cancer-free survival (from
time of study treatment to local tumor progression), extrahepatic … Authors varied in how these tumor characteristics
were described: mean number and size of tumors,
median … number and size of tumors, range of number
and size of tumors, percent solitary and nonsolitary
tumors … Hepatobiliary Cancers. Version 2. 2010. … Treatment of large and/
or multiple hepatic malignancies: open surgical approaches
of radiofrequency
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
November 01, 2009 - (e.g., lung, prostate, breast) and uncommon cancers (e.g., skull base
tumors, uveal melanomas). … cancer)
• Head and neck cancers, including malignancies of the brain (e.g., glioblastoma); of
the … the sclera for some ocular
cancers or in the uterus for some gynecologic malignancies), or may be directly … ), and cancers of the head and neck (brain tumors, and tumors arising from skull base,
cervical spine … Treated cancers included malignant tumors in the head, neck and spine, non-
small cell lung cancer, prostate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-muscle-invasive_research-protocol.pdf
July 21, 2014 - Stage 2 cancers are muscle-invasive, and higher stage cancers
invade beyond the muscle layer into surrounding … Stage T4b cancer, in which the tumor has spread to the pelvis or abdominal
wall, bladder cancer involving … Approximately 25 percent of newly diagnosed bladder cancers present as stage 2
or higher tumors.6 Once … These include the stage of the cancer, tumor grade, whether the tumor
is an initial tumor or a recurrence … and Treatment of Non-
metastatic Muscle-invasive Bladder Cancer
1. exp Urinary Bladder Neoplasms/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
July 01, 2023 - The cancer conditions included acute leukemias, clinically advanced multiple
myeloma, solid tumors with … Management of the
neck in early oral cancers: Is the verdict out? … potential dental focal infection
before the first cycle of chemotherapy in patients
with hematologic malignancy … searched: December 16, 2022
1 Bone Marrow Transplantation/ or exp Immunosuppression Therapy/ or exp Neoplasms … leukemia* or lymphom* or malig* or
neoplas* or onco* or radiat* or radiotherap* or "radio-therap*" or tumor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - non-dermatologic malignancy (174,650 new cases) and the second
leading cause of cancer death (31,620 … With AS, tumors are not
immediately removed, irradiated, or ablated.3, 4 Instead, tumors are monitored … Stage 1
T2= tumor Stage 2
T3= tumor Stage 3
T4= tumor Stage 4
WMD= weighted mean differences
WW … / (121506)
2 (prostat* and (neoplasm* or cancer* or carcinoma*)).ti,ab. (142514)
3 watchful … / (9241)
2 (prostat$.ti,ab. or Prostate/) and (cancer.ti,ab. or Neoplasms/ or neoplasm$.mp. or
-
effectivehealthcare.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research-protocol
July 21, 2014 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … . 7 As many as 70 percent of Non-MIBC tumors will recur after initial treatment, with a 10-20 percent … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … treatment decision-making, based on available prognostic factors including grade, stage, number and size of tumors … and Treatment of Non-metastatic Muscle-invasive Bladder Cance r
exp Urinary Bladder Neoplasms/ (
-
effectivehealthcare.ahrq.gov/health-topics/cancer/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancer-key-questions.pdf
January 01, 2020 - Key Questions - Optimal Medical Treatments for Non-Metastatic Gastric Cancers
Optimal Medical Treatments … for Non-Metastatic Gastric Cancers
Background
Gastric cancer is the fifth most common cancer worldwide … , gastrointestinal stromal tumors
(GIST)).. … rare gastric
cancers
Interventions
KQ 1
KQ 2
KQ 3. … Global
Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36
Cancers
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
August 23, 2010 - cancer in men and women, accounting
for nearly half of all malignancies. … examine how these emerging non-invasive
imaging modalities could be used to help diagnose cancerous tumors … whether or not patients have a
history of other malignancies. … The rationale for this is the growing recognition of skin cancer as
a leading form of second malignancy … Association
of nonmelanoma skin cancer with second malignancy. Cancer 2004 January
1;100(1):130-8.
-
effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - How do tumor characteristics affect outcomes? … volume to identify low-,
intermediate-, and high risk
tumors. … OR "prostate cancer"
AND
Limits: Meta-Analysis
OR
prostatic neoplasms OR "prostate cancer"
AND … OR "prostate cancer"
AND
prostate-specific antigen OR "tumor characteristics" OR "tumor volume" OR … volume
to identify low-, intermediate-, and high
risk tumors.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - How do tumor characteristics affect outcomes? … volume to identify low-,
intermediate-, and high risk
tumors. … OR "prostate cancer"
AND
Limits: Meta-Analysis
OR
prostatic neoplasms OR "prostate cancer"
AND … OR "prostate cancer"
AND
prostate-specific antigen OR "tumor characteristics" OR "tumor volume" OR … volume
to identify low-, intermediate-, and high
risk tumors.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
July 01, 2017 - Renal
cell carcinoma accounts for more than 94 percent of kidney
malignancies. … treatment for patients with clinical
stage T1a tumors (≤4 cm in diameter) and T1b tumors (4–7
cm) … (9,401) A positive relationship between tumor size and malignancy
risk was found.
1.326 (1.220 to … and malignancy risk was found. … potential of tumors treated with RN.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
April 01, 2013 - "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND
("progression-free survival … "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND
("progression-free survival … "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND
("progression-free survival … "[Mesh] OR ((ovary OR ovarian) AND (cancer OR cancers OR neoplasms OR
carcinoma*))) AND ("progression-free … ") AND (cancer OR cancers OR carcinoma* OR neoplasms))) AND
("progression-free survival" OR "time to
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer-update_disposition.pdf
December 09, 2014 - , not
salivary gland cancers. … Listing
patients with salivary gland cancers as head and
neck cancers is understandable since they … Therefore,
because use of brachytherapy alone for
primary management of head and neck
malignancies … Historically, it has been used extensively
in many tumor types, including head and
neck cancer. … Therefore,
because use of brachytherapy alone for
primary management of head and neck
malignancies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
December 01, 2014 - localized prostate cancer.2 After biopsy confirms
the presence of the cancer, pathologists report tumor … classification is based on the extent
of primary tumor (T stages), whether cancer has spread to
the … Clinicians make pretreatment assessment of whether
prostate cancer is localized by determining tumor … Ten to 15 years
ago, prostate cancers were primarily detected by digital
rectal examination or tissue … Currently, the vast majority of
prostate cancers detected in the United States are found by
PSA testing